ARCHIVES

Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now

This article is from The Cancer Letter archive.

Vol. 09 No. 46 | December 2, 1983

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

August 10, 2012

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

NCI Advisors Approve New Grant Programs In Systems Genetics, Tumor Stem Cells.

November 23, 2007

NCCN Updates Myeloma Clinical Practice Guidelines

September 26, 2003

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

July 24, 2009

Bristol-Myers Awards 42.5 Million In Cancer Grants

October 21, 1977